To include your compound in the COVID-19 Resource Center, submit it here.

UCB sales and marketing update

UCB launched Briviact brivaracetam in the U.S. to treat partial-onset seizures in epileptics ages 16 and older.

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE